期刊文献+

ErbB2基因沉默介导PI3K/Akt/eNOS信号通路对卵巢癌细胞生物学特性影响 被引量:2

EFFECT OF ERBB2 GENE SILENCING ON THE BIOLOGICAL CHARACTERISTICS OF OVARIAN CANCER CELLS BY MEDIATING THE PI3K/AKT/ENOS SIGNALING PATHWAY
下载PDF
导出
摘要 目的探讨ErbB2基因沉默介导PI3K/Akt/eNOS信号通路对卵巢癌细胞生物学特性的影响及机制。方法选取对数生长期人卵巢癌细胞株HO8910细胞分为5组:空白对照组(不转染任何序列)、阴性对照组(转染空载体质粒)、siErbB2组(转染siRNA序列)、wortmannin组(转染PI3K/Akt/eNOS信号通路抑制剂wortmannin)、siErbB2+IGF-1组(转染siRNA序列+PI3K/Akt/eNOS信号通路激动剂IGF-1)。采用实时定量逆转录聚合酶链反应(qRT-PCR)和Western blot检测ErbB2、Akt、PI3K、eNOS、Caspase-3、Bax和Bcl-2的mRNA和蛋白表达水平,同时检测细胞增殖、凋亡、迁移和侵袭的变化。结果与空白对照组比较,siErbB2组和wortmannin组卵巢癌细胞中Akt、PI3K、eNOS和Bcl-2的mRNA和蛋白表达量显著下降,而Caspase-3、Bax的mRNA和蛋白表达量则显著增加(F=3.58~8.69,P均<0.05),细胞增殖能力、侵袭能力、迁移能力均显著下降(F=8.84~15.67,P均<0.05),细胞凋亡率上升(F=9.46,P<0.05);siErbB2组ErbB2表达明显下降(P<0.05)。与siErbB2组相比,siErbB2+IGF-1组ErbB2、Akt、PI3K、eNO S和Bcl-2的mRNA和蛋白表达量显著下降(P均<0.05),Caspase-3、Bax的mRNA和蛋白表达量显著增加(P均<0.05),细胞增殖能力、侵袭能力、迁移能力均明显下降(P均<0.05),细胞凋亡率上升(P<0.05)。结论ErbB2基因沉默可抑制PI3K/Akt/eNOS信号通路,从而抑制卵巢癌细胞增殖,促进细胞凋亡。而PI3K/Akt/eNOS信号通路激活可逆转ErbB2基因沉默作用,促进卵巢癌细胞增殖并抑制细胞凋亡。 Objective To investigate the effect of ErbB2 gene silencing on the biological characteristics of ovarian cancer cells by mediating the PI3K/Akt/eNOS signaling pathway and its mechanism.Methods Human ovarian cancer HO8910 cells in the logarithmic growth phase were divided into blank control group(without transfection of any sequence),negative control group(transfected with empty vector plasmid),siErbB2 group(transfected with siRNA sequence),wortmannin group(transfected with the PI3K/Akt/eNOS signaling pathway inhibitor wortmannin),and siErbB2+IGF-1 group(transfected with siRNA sequence and the PI3K/Akt/eNOS signaling pathway agonist IGF-1).Quantitative reverse transcription-polymerase chain reaction and Western blot were used to measure the mRNA and protein expression levels of ErbB2,Akt,PI3K,eNOS,Caspase-3,Bax,and Bcl-2,and the changes in cell proliferation,apoptosis,migration,and invasion were observed.Results Compared with the blank control group,the siErbB2 group and the wortmannin group had significant reductions in the mRNA and protein expression levels of Akt,PI3K,eNOS,and Bcl-2 and significant increases in the mRNA and protein expression levels of Caspase-3 and Bax in ova-rian cancer cells(F=3.58-8.69,P<0.05),as well as significant reductions in cell proliferation,invasion,and migration abilities(F=8.84-15.67,all P<0.05)and a significant increase in cell apoptotic rate(F=9.46,P<0.05);the siErbB2 group had a significant reduction in the expression of ErbB2(P<0.05).Compared with the siErbB2 group,the siErbB2+IGF-1 group had signi-ficant reductions in the mRNA and protein expression levels of ErbB2,Akt,PI3K,eNOS,and Bcl-2(all P<0.05),significant increases in the mRNA and protein expression of Caspase-3 and Bax(all P<0.05),significant reductions in cell proliferation,invasion,and migration abilities(all P<0.05),and a significant increase in cell apoptotic rate(P<0.05).Conclusion ErbB2 gene silencing can inhibit the PI3K/Akt/eNOS signaling pathway, thereby inhibiting the proliferation of ovarian cancer cells and promoting cell apoptosis. The activation of the PI3K/Akt/eNOS signaling pathway can reverse the effect of ErbB2 gene silencing, promote the proli-feration of ovarian cancer cells, and inhibit cell apoptosis.
作者 石巍 王俊耐 张慧芳 SHI Wei;WANG Junnai;ZHANG Huifang(Department of Obstetrics and Gynecology,The Third Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China)
出处 《青岛大学学报(医学版)》 CAS 2021年第2期222-227,共6页 Journal of Qingdao University(Medical Sciences)
基金 河南省医学科技攻关计划项目(2018020189)。
关键词 基因 ERBB-2 基因沉默 PI3K/Akt/eNOS信号通路 卵巢肿瘤 细胞增殖 细胞凋亡 细胞运动 肿瘤侵润 genes,erbB2 gene silencing PI3K/Akt/eNOS signaling pathway ovarian neoplasms cell proliferation apoptosis cell movement neoplasm invasiveness
  • 相关文献

参考文献4

二级参考文献79

  • 1张超,杨娜,章雄文,丁健.靶向PI3K-Akt-mTOR信号通路抑制剂的研究进展[J].中国癌症杂志,2006,16(12):1064-1070. 被引量:22
  • 2Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signaling controls tumor cell growth. Nature, 2006, 441 (7092): 424-430.
  • 3Pisick E,Jagadeesh S, Salgia R. Receptor tyrosine kinases and inhibitors in lung cancer. Sci World J, 2004, 4: 589-604.
  • 4Samuels Y, Wang Z, Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science, 2004, 304(5670): 554.
  • 5Hartmann W, Digon-Sontgerath B, Koch A, et al. Phosphatidrl inositol 3'-ki- nase/AKT signaling is actived in medulloblastoma cell proliferation and is associated with reduced expression of PTEN. Cli Cancer Res, 2006, 12 (10): 3019-3027.
  • 6Engelmann JA. Targeting PI3K signaling in cancer: opportunities, challenges and limitations. Nat Rev Cancer, 2009, 9(8): 550-562.
  • 7Franke TF. PI3K/Akt: getting it right matters. Oncogene, 2008, 27(50): 6473-6488.
  • 8Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene, 2008, 27(41): 5497-5510.
  • 9Sheng SJ, Ojao M, Pardee AB. Metastasis and AKT activation. J Cell Physiol, 2009, 218(3): 451-454.
  • 10Carnero A, Blanco-Aparicio C, Renner O, et al. The PTEN/PI3K/AKT signaling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets, 2008, 8(3): 187-198.

共引文献52

同被引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部